Scientific topics
Keywords
ITMO
Virginie San Martin Tardif Assistant Professor (CPJ)
Course and current status
|
2024-2029 |
CPJ |
INSERM U1180, Paris Saclay |
|
2021-2023 |
PI – Chaire d’excellence |
INSERM U1096, Rouen |
|
2020-2021 |
Researcher en CDD |
INSERM U974, Paris Sorbonne |
|
2018-2020 |
Researcher en CDD |
INSERM U1096, Rouen |
|
2014-2018 |
Post-doctoral fellow then Instructor |
VGTI, FL then Drexel University, PA |
|
2011-2014 |
Research Associate |
The Scripps Research Institute, CA |
|
2007-2010 |
PhD Fellow |
INSERM 1064, Nantes |
Scientific summary
Dr. Tardif brings over a decade of dynamic and dedicated training in immunology, which began with a PhD at the CRTI in Nantes, where she explored the cutting-edge field of tolerogenic dendritic cells. In 2011, she took her expertise to the internationally renowned Scripps Research Institute in La Jolla, California, where she investigated immune dysregulation in lupus models and contributed to innovative regenerative medicine strategies aimed at treating autoimmune multiple sclerosis.
Driven by a passion for translational research, she joined Drexel College of Medicine in Philadelphia in 2014. There, she delved into the biology of human follicular helper T cells and their regulatory mechanisms, with the goal of leveraging these insights to design next-generation vaccine approaches and novel therapies for autoimmune diseases.Throughout her career in US, Dr. Tardif has distinguished herself through impactful contributions, including two publications as co–senior author, promotion to Instructor faculty, and co-invention of a U.S. patent (US20220133885A1).
In 2021, she integrated the UMR1096 HF team in Rouen with independent funding, where she has investigated the role of co-signaling pathways, such as CTLA-4, in cardiac dilation.
Since 2025, she has held a CPJ position, continuing to expand her research at the interface of immunology and cardiology, with a particular focus on the critical role of immune cells in cardiac remodeling. She has been appointed at the early-career editorial board at Circulation Research (2026).
